CTOs on the Move

Delaware Hospice

www.delawarehospice.org

 
Delaware Hospice is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Wilmington, DE. To find more information about Delaware Hospice, please visit www.delawarehospice.org
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Horizon Orthopedic

Horizon Orthopedic is a Brook Park, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Talkspace

Talkspace is a digital behavioral technology healthcare company. Its signature psychotherapy product connects individual clients with a network of thousands of licensed therapists through an easy-to-use and HIPAA-compliant web and mobile platform. With Talkspace, clients can send their dedicated therapists text, video, and voice messages anytime, from anywhere, and engage in live video sessions. Talkspace also provides psychiatry services, including prescription fulfillment, adolescent therapy and couples counseling. To date, the service has been used by over 1.5 million people.

SCR Medical Transportation

SCR Medical Transportation is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Smart Data Systems

Smart Data Systems is a Fayetteville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III